Clinical trials: Smith-Lemi-Opitz Syndrome

Smith-Lemi-Opitz Syndrome

A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome

• Withdrawn
• Age: All ages
• Observational study

Background: Smith-Lemli-Opitz syndrome (SLOS) is a genetic disorder that prevents the body from making enough cholesterol. People who have SLOS often need to take extra cholesterol, either in food or in supplements, for their…

Trial name

NCT01413425

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)